X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Clinical trial NCT03215693 · UNKNOWN
Trial details
- NCT number
- NCT03215693
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2020-03-09
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.